Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2003
11/25/2003US6653288 Combined with hormonal growth promoter dissolved in polymer free solvent; promoting animal growth and inhibiting parasitic infection/ infestation
11/25/2003US6653284 Keratinocyte growth factor-2 formulations
11/25/2003US6653104 Immunotoxins, comprising an internalizing antibody, directed against malignant and normal cells
11/25/2003US6652885 Complexing drug with diketopiperazine; washing; separation of impurities
11/25/2003US6652884 Method for the treatment of solid tumors by albumin microparticles incorporating paclitaxel
11/25/2003US6652881 Micronized, quick dissolving; water, polysorbate 80 and sodium lauryl sulfate
11/25/2003US6652879 Improving the palatability of fish oil medicinals; gelatin, gelatin softener, water and water soluble flavoring agent
11/25/2003US6652875 Casein formulations for the delivery of bioactive constituents
11/25/2003US6652873 Compositions and methods for enhancing receptor-mediated cellular internalization
11/25/2003US6652865 For decreasing the effect of intestinal metabolism on a drug
11/25/2003US6652864 Administering compound of nerve growth factor-enzymatically cleavable amide linker-viricide
11/25/2003US6652852 Specificity for CD20 antigen
11/25/2003US6652850 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity
11/25/2003US6652837 Preparation of novel particles for inhalation
11/25/2003CA2266666C Pharmaceutical formulations of corticotropin releasing factor having improved stability in liquid form
11/25/2003CA2258811C Formulation for use in the prevention of pathogen induced diseases including hiv and hsv
11/25/2003CA2119145C Ferrite particles and therapeutic and diagnostic uses therefore
11/21/2003CA2385529A1 Stable dosage forms comprising atorvastatin calcium
11/20/2003WO2003096017A1 Methods and compositions for inducing an immune response
11/20/2003WO2003095641A1 Intracellular protein delivery compositions and methods of use
11/20/2003WO2003095626A2 Purified composition of bispecific molecules and methods of production
11/20/2003WO2003095522A1 Targeted hydrophilic polymer, binders with interferon and medical composite comprising above binders
11/20/2003WO2003095498A1 Complex of organic medicines and beta-cyclodextrin derivatives and its preparing process
11/20/2003WO2003095496A1 Active carbohydrate containing protecting reagents for chemical modifications, their production and use
11/20/2003WO2003095403A1 Polyunsaturated linear aldehydes and their derivatives with anti-radical and anti-tumoral activity
11/20/2003WO2003095029A1 Bisphosphonic acid for the treatment and prevention of osteoporosis
11/20/2003WO2003094974A1 Complexes for the delivery of biologically-active material to cells
11/20/2003WO2003094973A1 Agent and method for transporting biologically active molecules in cells
11/20/2003WO2003094972A2 Fap-activated anti-tumor prodrugs
11/20/2003WO2003094970A1 A fungus inhibiting biological compound
11/20/2003WO2003094963A2 Methylated immunostimulatory oligonucleotides and methods of using the same
11/20/2003WO2003094951A1 Soluble formulations comprising insulin aspart and insulin detemir
11/20/2003WO2003094942A1 Soluble composition containing sporopollenin and the use thereof
11/20/2003WO2003094930A1 Embolization using degradable crosslinked hydrogels
11/20/2003WO2003094929A2 Preblocking with non-ha gags increases effectiveness of ha conjugated anticancer agents
11/20/2003WO2003094925A1 Injectable bisphosphonate formulations
11/20/2003WO2003094917A1 Vintoperol-containing medicinal composition for transdermal administration
11/20/2003WO2003094905A1 Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders
11/20/2003WO2003094896A1 A method to improve surface properties of pharmaceutical tablets
11/20/2003WO2003094894A1 Nanoparticulate nystatin formulations
11/20/2003WO2003094892A1 Conversion of amorphous material to a corresponding crystalline material by spray drying and utilization of the crystalline spray dried material in drug formulations
11/20/2003WO2003094891A1 Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs
11/20/2003WO2003094890A1 Capsules for dry powder inhalers and methods of making and using same
11/20/2003WO2003094888A1 Processes for forming a drug delivery device
11/20/2003WO2003094884A1 Derivatised particulate inhalation carriers
11/20/2003WO2003094842A2 Conjugates comprising central nervous system active drug
11/20/2003WO2003094828A2 Cancer vaccines and methods of using the same
11/20/2003WO2003094827A2 Dispersions of lipids for use as therapeutic and cosmetic agents and intracellular delivery vehicles
11/20/2003WO2003094808A1 Methods for therapeutic treatment of carpal tunnel syndrome
11/20/2003WO2003094617A2 Use of vegf for treating bone defects
11/20/2003WO2003072016A3 Pharmaceutical compositions in particulate form
11/20/2003WO2003066023A9 A stable pharmaceutical formulation comprising torsemide modification ii
11/20/2003WO2003059848A3 Hybrid immobilized catalytic system with controlled permeability
11/20/2003WO2003059331A3 Medicinal aerosol compositions with an amide and/or ester containing excipient compound
11/20/2003WO2003059317A3 Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient
11/20/2003WO2003049772A3 Guanidinium transport reagents and conjugates
11/20/2003WO2003049719A3 Matrices for stabilizing and controlled release of problematic substances
11/20/2003WO2003041632A3 Eutectic-based self-nanoemulsified drug delivery system
11/20/2003WO2003039465A3 Treating canker sores with patches to speed healing and relieve pain
11/20/2003WO2003037272A3 Thymosin alpha 1 peptide/polymer conjugates
11/20/2003WO2003024357A3 Microfabricated nanopore device for sustained release of therapeutic agent
11/20/2003WO2003020210A3 Vaginal delivery of chemotherapeutic agents and inhibitors of membrane efflux systems for cancer therapy
11/20/2003WO2003018075A3 Transdermal therapeutic system with fentanyl or related substances
11/20/2003WO2003017972A8 Multi-component polymeric systems with reverse thermal gelation behaviour (e.g. peo-ppo copolymers)
11/20/2003WO2003008444A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/20/2003WO2002095022A3 Sequence-specific dna binding compounds and their use in targeting telomeres and other dna sequences
11/20/2003WO2002069906A3 Compounds and methods for the treatment of urogenital disorders
11/20/2003WO2002062395A3 A method and system for introducing a gene into a human stem cell
11/20/2003WO2002053189A3 Immunogenic complex
11/20/2003WO2002051445A3 An oral and parenteral pharmaceutical formulation comprising a low molecular weight thrombin inhibitor prodrug
11/20/2003WO2002041910A3 Methods and compositions for the treatment of diseases of the eye
11/20/2003WO2002028836A9 Novel crystalline forms of a factor xa inhibitor
11/20/2003WO2002026191A3 Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
11/20/2003WO2002002506A8 Compounds to treat alzheimer's disease
11/20/2003WO2002002505A8 Compounds to treat alzheimer's disease
11/20/2003US20030216589 Amino acids which deliver active agents to selected biological systems in increased or improved bioavailability
11/20/2003US20030216552 Comprises monoclonal antibody capable of binding cytokine for treating tumors; compeptive binding
11/20/2003US20030216542 Modified insulin for delivery to lungs by breathing and treatment of diabetes
11/20/2003US20030216541 Systemic administration of a therapeutic preparation
11/20/2003US20030216475 Pharmaceutical composition
11/20/2003US20030216470 Method for treating ileus
11/20/2003US20030216466 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
11/20/2003US20030216447 Compositions and method for treating infection in cattle and swine
11/20/2003US20030216418 Novel compositions comprising trimetrexate and methods of their synthesis and use
11/20/2003US20030216353 Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
11/20/2003US20030216352 Multicomponent complex for use with a substrate
11/20/2003US20030216347 Genetic material composed of a polynucleotide complexed with an amphipathic compound, a polymer or a nonviral vector is delivered to the parenchymal cell altering its endogenous properties
11/20/2003US20030216346 Gene carrier
11/20/2003US20030216335 Treating endometriosis by contacting the subject with a nucleic acid that modulates the expression of VEGF, VEGFR1, and/or VEGFR2
11/20/2003US20030216331 Micelles
11/20/2003US20030216320 Peptide-based multimeric targeted contrast agents
11/20/2003US20030216313 Long-acting hormone and growth factor compositions and uses thereof
11/20/2003US20030216309 Binding peptides specific for the extracellular domain of ErbB2 and uses therefor
11/20/2003US20030216307 Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release
11/20/2003US20030216302 Desmopressin or its salts in a carrier, a buffer, a para-hydroxybenzoate preservative, and a cosolvent; stable at room temperatures; suitable for nasal administration
11/20/2003US20030216298 Peptide conjugated anti-cancer prodrugs
11/20/2003US20030216297 Pharmaceutical composition
11/20/2003US20030216296 Amino acid sequences that mediate effective delivery of nucleic acids into cells and tissues, optionally using liposomes
11/20/2003US20030216289 Treating leukemia or a solid tumor
11/20/2003US20030216287 N-(2-chlorophenyl) hydroxy- or alkoxyalkanamides, e.g.,N-(5-Chloro-2-hydroxyphenyl)-2-(2-hydroxyphenoxy)acetamid e); can deliver a broad range of active agents by various routes.
1 ... 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 ... 1712